ReviewIndian journal of ophthalmology2020
Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy - An update.
Review in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 23 citations in OpenAlex.
- Association between human immunodeficiency virus infection and the risk of glaucoma: a real-world multicenter cohort study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Risk of uveitis in patients with human immunodeficiency virus: a cohort study through TriNetX database.AIDS research and therapy · 2025Article
- [Peripheral ulcerative keratitis with necrotizing scleritis, manifestation of granulomatosis with polyangiitis].Revista medica del Instituto Mexicano del Seguro Social · 2025Article
- Prevalence of uveitis in syphilis patients in Taiwan.Emerging microbes & infections · 2024Article
- Immune recovery uveitis: a focus review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024Review
- From Bedside to Diagnosis: The Role of Ocular Fundus in Systemic Infections.Journal of clinical medicine · 2023Review
- Ophthalmological Manifestations in People with HIV from Northeastern Romania.Medicina (Kaunas, Lithuania) · 2023Article
- Autoimmune Inflammatory Eye Disease: Demystifying Clinical Presentations for the Internist.Current allergy and asthma reports · 2023Review
- Human Immunodeficiency Virus and Uveitis.Viruses · 2023Review
- Case of HIV presenting as retinal artery occlusion with further complications of Burkitt's lymphoma and CMV retinitis.BMJ case reports · 2023Article
- Unilateral Cytomegalovirus Retinitis in a Child With Acute Lymphoblastic Leukemia While on Maintenance Chemotherapy.Cureus · 2021Article
- Ocular manifestations of people living with HIV in Tunisia.Southern African journal of HIV medicine · 2021Article
- Exploring a New Era in Uveitis.Indian journal of ophthalmology · 2020Article
- Immune Privilege: The Microbiome and Uveitis.Frontiers in immunology · 2020Review
- Ocular involvement in highly treatment-experienced patients with HIV.Romanian journal of ophthalmologyArticle
- Keratitis patterns in patients with human immunodeficiency virus: A 10-year retrospective study.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological SocietyArticle
- Rifabutin induced hypopyon uveitis mimicking endophthalmitis as a manifestation of IRU in patients with HIV.Indian journal of pharmacologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraocular inflammation in patients with human immunodeficiency virus (HIV) infection is commonly due to infectious uveitis. Ocular lesions due to opportunistic infections (OI) are the most common and have been described extensively in the pre highly active antiretroviral therapy (HAART) era. Many eye lesions were classified as acquired immunodeficiency syndrome (AIDS) defining illnesses. HAART-associated improvement in immunity of the individual has changed the pattern of incidence of these hitherto reported known lesions leading to a marked reduction in the occurrence of ocular OI. Newer ocular lesions and newer ocular manifestations of known agents have been noted. Immune recovery uveitis (IRU), the new menace, which occurs as part of immune recovery inflammatory syndrome (IRIS) in the eye, can present with significant ocular inflammation and can pose a diagnostic and therapeutic challenge. Balancing the treatment of inflammation with the risk of reactivation of OI is a task by itself. Ocular involvement in the HAART era can be due to the adverse effects of some systemic drugs used in the management of HIV/AIDS. Drug-associated retinal toxicity and other ocular side effects are being increasingly reported. In this review, we discuss the ocular manifestations in HIV patients and its varied presentations following the introduction of HAART, drug-associated lesions, and the current treatment guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.